Vanderbilt University School of Medicine

Massion, Pierre Pascal , M.D.
Professor of Medicine
Ingram Professor of Cancer Research
Professor of Cancer Biology

Lab Url: N/A

Phone Number: 615-936-2256

Email Address:pierre.massion@vanderbilt.edu

Massion, Pierre's picture

Office Address   Mailing Address

2200 Pierce Ave 640 PRB

640 PRB 6838


Research Keywords
Early detection, lung cancer, preinvasive lesions, array comparative genomic hybridization, proteomics, chemoprevention.,Cancer,Chromosome,Genomics,Mass spectroscopy,Proteomics,Pulmonary,Translation

Research Specialty
The laboratory of Dr. Massion emphasis is on lung tumorigenesis and on using genomic and proteomic approaches to identify molecular markers of lung neoplasia and to test those in multidisciplinary early detection strategies.

Research Description
1. Role of chromosome 3q in lung cancer. Selection of candidate genes driving a genomic amplicon on Chromosome 3q. Focus on functional genomics for candidate driver genes on chromosome 3q such as p63 and PIK3CA. RO1 funded.

2. Proteomic approach to preinvasive lung cancer. Protein profiling of preinvasive lesions in bronchial biopsy and invasive lung cancer by MALDI MS; Identification of discriminatory proteins by LC-MSMS proteomics; Image analysis. funded by RO1 and SPORE in lung cancer.

3. Lung cancer biomarker discovery and validation. Identification of discriminatory proteins between lung cancer and controls after multidimensional mass spectrometry analysis of biological specimen and Phage-display recombinant antibody library (serum, plasma or pleural fluid). Funded by Vanderbilt SPORE in lung cancer, VA Merit review grant, ASCO research award and EDRN Clinical Validation Center (U01).

4. Inflammation and cancer. We are working on 3 proteins. PPAR delta in lung tumorigenesis (Pedchenko, 2008), Role of serum amyloid A in regulating apoptosis in lung cancer cells, and pIgR as a potential tumor suppressor gene in lung cancer (Polosukhin, 2007). Work supported by Damon Runyon Foundation and a Vanderbilt Discovery Grant.

Clinical Research Description
Active Clinical Trials:
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease --This study is currently recruiting patients. http://clinicaltrials.gov/ct/gui/show/NCT00084409?order=2

Publications
Hassanein, M, Hoeksema, MD, Shiota, M, Qian, J, Harris, BK, Chen, H, Clark, JE, Alborn, WE, Eisenberg, R, Massion, PP. SLC1A5 Mediates Glutamine Transport Required for Lung Cancer Cell Growth and Survival. Clin Cancer Res, 19(3), 560-70, 2013.

Hassanein, M, Callison, JC, Callaway-Lane, C, Aldrich, MC, Grogan, EL, Massion, PP. The state of molecular biomarkers for the early detection of lung cancer. Cancer Prev Res (Phila), 5(8), 992-1006, 2012.

Kikuchi, T, Hassanein, M, Amann, JM, Liu, Q, Slebos, RJ, Rahman, SM, Kaufman, JM, Zhang, X, Hoeksema, MD, Harris, BK, Li, M, Shyr, Y, Gonzalez, AL, Zimmerman, LJ, Liebler, DC, Massion, PP, Carbone, DP. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers. Mol Cell Proteomics, 11(10), 916-32, 2012.

Ocak, S, Chen, H, Callison, C, Gonzalez, AL, Massion, PP. Expression of focal adhesion kinase in small-cell lung carcinoma. Cancer, 118(5), 1293-301, 2012.

Ocak, S, Pedchenko, TV, Chen, H, Harris, FT, Qian, J, Polosukhin, V, Pilette, C, Sibille, Y, Gonzalez, AL, Massion, PP. Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis. Eur Respir J, 39(5), 1171-80, 2012.

Pecot, CV, Li, M, Zhang, XJ, Rajanbabu, R, Calitri, C, Bungum, A, Jett, JR, Putnam, JB, Callaway-Lane, C, Deppen, S, Grogan, EL, Carbone, DP, Worrell, JA, Moons, KG, Shyr, Y, Massion, PP. Added value of a serum proteomic signature in the diagnostic evaluation of lung nodules. Cancer Epidemiol Biomarkers Prev, 21(5), 786-92, 2012.

Deppen, S, Putnam, JB, Andrade, G, Speroff, T, Nesbitt, JC, Lambright, ES, Massion, PP, Walker, R, Grogan, EL. Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease. Ann Thorac Surg, 92(2), 428-32; discussion 433, 2011.

Grogan, EL, Weinstein, JJ, Deppen, SA, Putnam, JB, Nesbitt, JC, Lambright, ES, Walker, RC, Dittus, RS, Massion, PP. Thoracic operations for pulmonary nodules are frequently not futile in patients with benign disease. J Thorac Oncol, 6(10), 1720-5, 2011.

Hassanein, M, Rahman, JS, Chaurand, P, Massion, PP. Advances in proteomic strategies toward the early detection of lung cancer. Proc Am Thorac Soc, 8(2), 183-8, 2011.

Isbell, JM, Deppen, S, Putnam, JB, Nesbitt, JC, Lambright, ES, Dawes, A, Massion, PP, Speroff, T, Jones, DR, Grogan, EL. Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluation. Ann Thorac Surg, 91(1), 227-33; discussion 233, 2011.

Kashikar, ND, Zhang, W, Massion, PP, Gonzalez, AL, Datta, PK. Role of STRAP in regulating GSK3I? function and Notch3 stabilization. Cell Cycle, 10(10), , 2011.

Polosukhin, VV, Cates, JM, Lawson, WE, Milstone, AP, Matafonov, AG, Massion, PP, Lee, JW, Randell, SH, Blackwell, TS. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J Pathol, 224(2), 203-11, 2011.

Polosukhin, VV, Cates, JM, Lawson, WE, Zaynagetdinov, R, Milstone, AP, Massion, PP, Ocak, S, Ware, LB, Lee, JW, Bowler, RP, Kononov, AV, Randell, SH, Blackwell, TS. Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 184(3), 317-27, 2011.

Rahman, SM, Gonzalez, AL, Li, M, Seeley, EH, Zimmerman, LJ, Zhang, XJ, Manier, ML, Olson, SJ, Shah, RN, Miller, AN, Putnam, JB, Miller, YE, Franklin, WA, Blot, WJ, Carbone, DP, Shyr, Y, Caprioli, RM, Massion, PP. Lung Cancer Diagnosis from Proteomic Analysis of Preinvasive Lesions. Cancer Res, 71(8), 3009-3017, 2011.

Su, Z, Dias-Santagata, D, Duke, M, Hutchinson, K, Lin, YL, Borger, DR, Chung, CH, Massion, PP, Vnencak-Jones, CL, Iafrate, AJ, Pao, W. A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer. J Mol Diagn, 13(1), 74-84, 2011.

Zhang, H, Liu, Q, Zimmerman, LJ, Ham, AJ, Slebos, RJ, Rahman, J, Kikuchi, T, Massion, PP, Carbone, DP, Billheimer, D, Liebler, DC. Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry. Mol Cell Proteomics, , , 2011.

Grogan, EL, Deppen, S, Pecot, CV, Putnam, JB, Nesbitt, JC, Shyr, Y, Rajanbabu, R, Ory, B, Lambright, ES, Massion, PP. Diagnostic characteristics of a serum biomarker in patients with positron emission tomography scans. Ann Thorac Surg, 89(6), 1724-8; discussion 1728-9, 2010. PMCID:3026702

Ocak, S, Yamashita, H, Udyavar, AR, Miller, AN, Gonzalez, AL, Zou, Y, Jiang, A, Yi, Y, Shyr, Y, Estrada, L, Quaranta, V, Massion, PP. DNA copy number aberrations in small-cell lung cancer reveal activation of the focal adhesion pathway. Oncogene, 29(48), 6331-42, 2010.

Massion, PP, Zou, Y, Uner, H, Kiatsimkul, P, Wolf, HJ, Baron, AE, Byers, T, Jonsson, S, Lam, S, Hirsch, FR, Miller, YE, Franklin, WA, Varella-Garcia, M. Recurrent genomic gains in preinvasive lesions as a biomarker of risk for lung cancer. PLoS One, 4(6), e5611, 2009. PMCID:2699220

Ocak, S, Chaurand, P, Massion, PP. Mass spectrometry-based proteomic profiling of lung cancer. Proc Am Thorac Soc, 6(2), 159-70, 2009. PMCID:2674226

Ocak, S, Sos, ML, Thomas, RK, Massion, PP. High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications. Eur Respir J, 34(2), 489-506, 2009. PMCID:3026702

Qian, J, Zou, Y, Rahman, JS, Lu, B, Massion, PP. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol Cancer Ther, 8(1), 101-9, 2009. PMCID:2674226

Wehbe, FH, Brown, SH, Massion, PP, Gadd, CS, Masys, DR, Aliferis, CF. A novel information retrieval model for high-throughput molecular medicine modalities. Cancer Inform, 8, 1-17, 2009. PMCID:2664697

DeBusk, LM, Massion, PP, Lin, PC. IkappaB kinase-alpha regulates endothelial cell motility and tumor angiogenesis. Cancer Res, 68(24), 10223-8, 2008. PMCID:2674226

Groseclose, MR, Massion, PP, Chaurand, P, Caprioli, RM. High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics, 8(18), 3715-24, 2008. PMCID:2927989

Massion, PP, Zou, Y, Chen, H, Jiang, A, Coulson, P, Amos, CI, Wu, X, Wistuba, I, Wei, Q, Shyr, Y, Spitz, MR. Smoking-related genomic signatures in non-small cell lung cancer. Am J Respir Crit Care Med, 178(11), 1164-72, 2008. PMCID:2720147

Pedchenko, TV, Gonzalez, AL, Wang, D, Dubois, RN, Massion, PP. Peroxisome Proliferator-Activated Receptor {beta}/{delta} Expression and Activation in Lung Cancer. Am J Respir Cell Mol Biol, , , 2008.

Qian, J, Massion, PP. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol, 3(3), 212-5, 2008.

Xu, BJ, Gonzalez, AL, Kikuchi, T, Yanagisawa, K, Massion, PP, Wu, H, Mason, SE, Olson, SJ, Shyr, Y, Carbone, DP, Caprioli, RM. MALDI-MS derived prognostic protein markers for resected non-small cell lung cancer. Proteomics Clin Appl, 2(10-11), 1508-17, 2008. PMCID:2674226

Albert, JM, Gonzalez, A, Massion, PP, Chen, H, Olson, SJ, Shyr, Y, Diaz, R, Lambright, ES, Sandler, A, Carbone, DP, Putnam, JB, Johnson, DH, Lu, B. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer. Cancer Epidemiol Biomarkers Prev, 16(9), 1845-51, 2007.

Polosukhin, VV, Lawson, WE, Milstone, AP, Egunova, SM, Kulipanov, AG, Tchuvakin, SG, Massion, PP, Blackwell, TS. Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia. Virchows Arch, 451(4), 793-803, 2007.

Taguchi, F, Solomon, B, Gregorc, V, Roder, H, Gray, R, Kasahara, K, Nishio, M, Brahmer, J, Spreafico, A, Ludovini, V, Massion, PP, Dziadziuszko, R, Schiller, J, Grigorieva, J, Tsypin, M, Hunsucker, SW, Caprioli, R, Duncan, MW, Hirsch, FR, Bunn, PA, Carbone, DP. Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: a multicohort cross-institutional study. J Natl Cancer Inst, 99(11), 838-46, 2007.

Yildiz, PB, Shyr, Y, Rahman, JS, Wardwell, NR, Zimmerman, LJ, Shakhtour, B, Gray, WH, Chen, S, Li, M, Roder, H, Liebler, DC, Bigbee, WL, Siegfried, JM, Weissfeld, JL, Gonzalez, AL, Ninan, M, Johnson, DH, Carbone, DP, Caprioli, RM, Massion, PP. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer. J Thorac Oncol, 2(10), 893-901, 2007.

Amann, JM, Chaurand, P, Gonzalez, A, Mobley, JA, Massion, PP, Carbone, DP, Caprioli, RM. Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Cancer Res, 12(17), 5142-50, 2006.

Massion, PP, Caprioli, RM. Proteomic strategies for the characterization and the early detection of lung cancer. J Thorac Oncol, 1(9), 1027-39, 2006.

Stacy, DR, Ely, K, Massion, PP, Yarbrough, WG, Hallahan, DE, Sekhar, KR, Freeman, ML. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck, 28(9), 813-8, 2006.

Amann, J, Kalyankrishna, S, Massion, PP, Ohm, JE, Girard, L, Shigematsu, H, Peyton, M, Juroske, D, Huang, Y, Stuart Salmon, J, Kim, YH, Pollack, JR, Yanagisawa, K, Gazdar, A, Minna, JD, Kurie, JM, Carbone, DP. Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer. Cancer Res, 65(1), 226-35, 2005.

Anumanthan, G, Halder, SK, Osada, H, Takahashi, T, Massion, PP, Carbone, DP, Datta, PK. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br J Cancer, 93(10), 1157-67, 2005. PMCID:2361493

Haruki, N, Kawaguchi, KS, Eichenberger, S, Massion, PP, Olson, S, Gonzalez, A, Carbone, DP, Dang, TP. Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res, 65(9), 3555-61, 2005.

Rahman, SM, Shyr, Y, Yildiz, PB, Gonzalez, AL, Li, H, Zhang, X, Chaurand, P, Yanagisawa, K, Slovis, BS, Miller, RF, Ninan, M, Miller, YE, Franklin, WA, Caprioli, RM, Carbone, DP, Massion, PP. Proteomic patterns of preinvasive bronchial lesions. Am J Respir Crit Care Med, 172(12), 1556-62, 2005. PMCID:2718455

Shinohara, ET, Gonzalez, A, Massion, PP, Chen, H, Li, M, Freyer, AS, Olson, SJ, Andersen, JJ, Shyr, Y, Carbone, DP, Johnson, DH, Hallahan, DE, Lu, B. Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma. Cancer, 103(8), 1685-92, 2005.

Wardwell, NR, Massion, PP. Novel strategies for the early detection and prevention of lung cancer. Semin Oncol, 32(3), 259-68, 2005.

Gonzalez, Adriana L, Roberts, Richard L, Massion, Pierre P, Olson, Sandra J, Shyr, Yu, Shappell, Scott B. 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation. Hum Pathol, 35(7), 840-9, 2004.

Lu, B, Gonzalez, A, Massion, P P, Shyr, Y, Shaktour, B, Carbone, D P, Hallahan, D E. Nuclear survivin as a biomarker for non-small-cell lung cancer. Br J Cancer, 91(3), 537-40, 2004. PMCID:2409840

Massion, Pierre P, Taflan, Peter M, Rahman, S M Jamshedur, Yildiz, Pinar, Shyr, Yu, Carbone, David P, Gonzalez, Adriana L. Role of p63 amplification and overexpression in lung cancer development. Chest, 125(5 Suppl), 102S, 2004.

Massion, Pierre P, Taflan, Peter M, Shyr, Yu, Rahman, S M Jamshedur, Yildiz, Pinar, Shakthour, Bashar, Edgerton, Mary E, Ninan, Matthew, Andersen, Jeremiah J, Gonzalez, Adriana L. Early involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression. Am J Respir Crit Care Med, 170(10), 1088-94, 2004.

Massion, Pierre P, Carbone, David P. From clinical and pathologic to molecular staging of lung cancer. Am J Respir Crit Care Med, 167(12), 1587-8, 2003.

Massion, Pierre P, Carbone, David P. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Respir Res, 4(1), 12, 2003. PMCID:314397

Massion, Pierre P, Taflan, Peter M, Jamshedur Rahman, S M, Yildiz, Pinar, Shyr, Yu, Edgerton, Mary E, Westfall, Matthew D, Roberts, John R, Pietenpol, Jennifer A, Carbone, David P, Gonzalez, Adriana L. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res, 63(21), 7113-21, 2003.

Yanagisawa, Kiyoshi, Shyr, Yu, Xu, Baogang J, Massion, Pierre P, Larsen, Paul H, White, Bill C, Roberts, John R, Edgerton, Mary, Gonzalez, Adriana, Nadaf, Sorena, Moore, Jason H, Caprioli, Richard M, Carbone, David P. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet, 362(9382), 433-9, 2003.

Aliferis, C F, Hardin, D, Massion, P P. Machine learning models for lung cancer classification using array comparative genomic hybridization. Proc AMIA Symp, , 7-11, 2002. PMCID:2244172

Massion, Pierre P, Kuo, Wen-Lin, Stokoe, David, Olshen, Adam B, Treseler, Patrick A, Chin, Koei, Chen, Chira, Polikoff, Daniel, Jain, Ajay N, Pinkel, Daniel, Albertson, Donna G, Jablons, David M, Gray, Joe W. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res, 62(13), 3636-40, 2002.

Godding, V, Sibille, Y, Massion, P P, Delos, M, Sibille, C, Thurion, P, Giffroy, D, Langendries, A, Vaerman, J P. Secretory component production by human bronchial epithelial cells is upregulated by interferon gamma. Eur Respir J, 11(5), 1043-52, 1998.

Massion, P P, Lind??n, A, Inoue, H, Mathy, M, Grattan, K M, Nadel, J A. Dimethyl sulfoxide decreases interleukin-8-mediated neutrophil recruitment in the airways. Am J Physiol, 271(5 Pt 1), L838-43, 1996.

Inoue, H, Hara, M, Massion, P P, Grattan, K M, Lausier, J A, Chan, B, Kaneko, T, Isono, K, Jorens, P G, Ueki, I F. Role of recruited neutrophils in interleukin-8 production in dog trachea after stimulation with Pseudomonas in vivo. Am J Respir Cell Mol Biol, 13(5), 570-7, 1995.

Massion, P P, H??bert, C A, Leong, S, Chan, B, Inoue, H, Grattan, K, Sheppard, D, Nadel, J A. Staphylococcus aureus stimulates neutrophil recruitment by stimulating interleukin-8 production in dog trachea. Am J Physiol, 268(1 Pt 1), L85-94, 1995.

Yoshihara, S, Chan, B, Yamawaki, I, Geppetti, P, Ricciardolo, F L, Massion, P P, Nadel, J A. Plasma extravasation in the rat trachea induced by cold air is mediated by tachykinin release from sensory nerves. Am J Respir Crit Care Med, 151(4), 1011-7, 1995.

Inoue, H, Massion, P P, Ueki, I F, Grattan, K M, Hara, M, Dohrman, A F, Chan, B, Lausier, J A, Golden, J A, Nadel, J A. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils. Am J Respir Cell Mol Biol, 11(6), 651-63, 1994.

Jorens, P G, Richman-Eisenstat, J B, Housset, B P, Massion, P P, Ueki, I, Nadel, J A. Pseudomonas-induced neutrophil recruitment in the dog airway in vivo is mediated in part by IL-8 and inhibited by a leumedin. Eur Respir J, 7(11), 1925-31, 1994.

Massion, P P, Inoue, H, Richman-Eisenstat, J, Grunberger, D, Jorens, P G, Housset, B, Pittet, J F, Wiener-Kronish, J P, Nadel, J A. Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro. J Clin Invest, 93(1), 26-32, 1994. PMCID:293717

Massion, P P, Funari, C C, Ueki, I, Ikeda, S, McDonald, D M, Nadel, J A. Parainfluenza (Sendai) virus infects ciliated cells and secretory cells but not basal cells of rat tracheal epithelium. Am J Respir Cell Mol Biol, 9(4), 361-70, 1993.


Postdoctoral Position Available
No

Postdoctoral Position Details
N/A

Updated Date
04/22/2011



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.